is ozempic a tirzepatide Buyer Beware: Off-brand Ozempic, Zepbound and Other Weight Loss Products Carry Undisclosed Risks What Are Tirzepatide and Semaglutide

Several GLP-1 agonists have FDA approval for other indications that may overlap with BED patient populations: Semaglutide (Wegovy) and liraglutide (Saxenda) are approved for chronic weight management in adults with obesity (BMI 30) or overweight (BMI 27) with at least one weight-related comorbidity Semaglutide (Ozempic), liraglutide (Victoza), dulaglutide (Trulicity), and tirzepatide (Mounjaro) are approved for type 2 diabetes management Tirzepatide (Zepbound) is approved for chronic weight management When clinicians prescribe GLP-1 agonists for BED, this constitutes off-label use a legal and common practice in medicine when evidence suggests potential benefit and approved treatments are inadequate

ERRs are nuclear receptors that sit upstream of mitochondrial biogenesis, fatty acid oxidation, and the aerobic gene program activated by endurance exercise

Another possible side effect is an increase in weight, which can concern some women

In the UK, obesity is thought to cost the NHS 6.1bn per year, government estimates show

Improved Blood Sugar Regulation : While primarily a weight loss tool, Semaglutide also enhances insulin sensitivity, which is beneficial for pre-diabetics or those with blood sugar concerns